Creating public awareness: State 2025 diabetes forecasts

Population Health Management

Volumn 15, Issue 4, 2012, Pages 194-200

  Rowley, William R ^a   Bezold, Clement ^a  

^a Institute for Alternative Futures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; COMMUNITY CARE; COST BENEFIT ANALYSIS; DEATH; DIABETES MELLITUS; HEALTH CARE COST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LIFESTYLE MODIFICATION; MEDICAL INFORMATION; PREVALENCE; REPRODUCTION; RISK ASSESSMENT; UNITED STATES;

AFRICAN AMERICANS; ASIAN AMERICANS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FORECASTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MARKOV CHAINS; MODELS, STATISTICAL; UNITED STATES;

EID: 84865206426     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0053     Document Type: Article

References (28)

1. Geiss LS, Cowie, CC. Type 2 diabetes and persons at high risk of diabetes. In: Narayan KM, Williams D, Gregg EW, Cowie CC, eds. Diabetes Public Health: From Data to Policy. New York, NY: Oxford University Press; 2011:18-21.
2. Imperatore G, Linder B, Pettitt DJ. Diabetes in the young. In: Narayan KM, Williams D, Gregg EW, Cowie CC. Diabetes Public Health: From Data to Policy. New York, NY: Oxford University Press; 2011:631-633.
3. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24:1936-1940.
4. Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Geiss LS, Narayan KM. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health CareManag Sci. 2003;6:155-164.
5. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care2006;29:2114-2116.
6. Boyle JP, Thompson TJ, Gregg EW, Baker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: Bynamic modeling of incidence, mortality and prediabetes prevalence. Popul Health Metr. 2010;8:29.
7. Centers for Disease Control and Prevention. Diabetes data and trends: State surveillance data. Available at: http://apps.nccd.cdc.gov/DDTSTRS/ StateSurvData.aspx. Accessed April 14, 2010.
8. US Census Bureau, Population Division. Interim projections of the total population for the United States and states: April 1, 2000 to July 1, 2030. Available at: http://www.census .gov/population/projections/SummaryTabA1.pdf. Accessed April 5, 2010.
9. US Census Bureau, Population Division. Interim projections of the population by selected age groups for the United States, regions, and divisions: April 1, 2000 to July 1, 2030.Available at: http://www.census.gov/population/ www/projections/files/SummaryTabC1.pdf Accessed September 8, 2011.
10. US Census Bureau. Table 4: Estimates of the resident population by race and Hispanic origin for the United States and states: July1, 2008. Available at: http://www.census.gov/popest/states/asrh/tables/SC-EST2008-04.xls. Accessed April 5, 2010.
11. US Census Bureau. Projected state populations by age, sex, race and Hispanic origin: 1995 to 2025. Available at: http://www.census.gov/population/ projections/state/stpjrace Accessed September 8, 2011.
12. Federation for American Immigrant Reform. State and local data. http://www.fairus.org/site/PageNavigator/facts/state-data.html. Accessed September 8, 2011.
13. diversitydata.org. Population demographics and diversity by metropolitan statistical areas. Available at: http://diversitydata.sph.harvard.edu. Accessed August 3, 2010.
14. Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed January 26, 2011.
15. Centers for Disease Control and Prevention. Diabetes Data and Trends. Age-adjusted percentage of adults with diabetes reporting visual impairment, by race/ethnicity, United States, 1997-2009. Available at: http://www.cdc.gov/ diabetes/statistics/visual/fig5.htm. Accessed May 8, 2010.
16. Centers for Disease Control and Prevention. Diabetes Data and Trends. Age-adjusted incidence of end-stage renal disease related to diabetes mellitus (ESRD-DM) per 100,000 diabetic population, by race/ethnicity and sex, United States, 1980-2006. Available at: http://www.cdc.gov/diabetes/statistics/esrd/ fig5.htm. Accessed May 9, 2010.
17. Centers for Disease Control and Prevention. Diabetes Data and Trends. Crude and age-adjusted hospital discharge rates for non-traumatic lower extremity amputation per 1,000 diabetic population, by race, United States 1980-2006. Available at: http://www.cdc.gov/diabetes/statistics/lea/table6.htm. Accessed May 8, 2010.
18. US Department of Health and Human Services; National Institutes of Health Available at Accessed 21 December 2010.
19. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National Vital Statistics Reports, Vol. 58, No. 19, May 20, 2010. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58-19.pdf Accessed September 8, 2011.
20. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: Final data for 2002. National Vital Statistics Reports, Vol. 53, No. 5, October 12, 2004. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr53/nvsr53-05.pdf. Accessed September 8, 2011.
21. Centers for Disease Control and Prevention. Diabetes Data &Trends. Number (in millions) of civilian, non-institutionalized persons with diagnosed diabetes, United States, 1980- 2009. Available at: http://www.cdc.gov/diabetes/ statistics/prev/national/figpersons.htm. Accessed October 8, 2010.
22. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;32:596-615.
23. Dall TM, Mann SE, Zhang Y, et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag. 2009;12:103-110.
24. Zhang Y, Dall TM, Mann SE, et al. The economic costs of undiagnosed diabetes. Popul Health Manag. 2009;12: 95-101.
25. Zhang Y, Dall TM, Chen Y, et al. Medical costs associated with prediabetes. Popul Health Manag. 2009;12:157-163.
26. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
27. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: Reality estimates for the year 2000. Diabetes Care. 2005;28:2130-2135.
28. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294.